About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us

About Us: Management


8/29/2014 - Daxor Corporation Announces Filing of Form N-CSR for June 30, 2014


6/19/2014 - Daxor to Explore Possible Partnership or Partial Sale of the Company


5/30/2014 - Heart Failure Study From the Mayo Clinic Utilizing Daxor’s BVA-100 Blood Volume Analyzer Published in Journal of the American College of Cardiology – Heart Failure



  Form N-CSR for Jun 30, 2014  
  Form N-Q for Mar 31, 2014  
  Form NSAR-B for Dec 31, 2013  
  Form N-Q for Sep 30, 2013  


Executive Team

Joseph Feldschuh, M.D.

President and CEO

David Frankel

Chief Financial Officer

Diane Meegan

Corporate Secretary

Gary Fischman, Ph.D.

Vice President, Research and Development
Board of Directors  

Joseph Feldschuh, M.D.

Chairman of the Board

Michael R. Feldschuh

Director of the Company

James A. Lombard

Director of the Company

Martin S. Wolpoff

Director of the Company

Robert Willens

Director of the Company

Bernhard Saxe

Director of the Company
Medical Advisory Board  

Philip Frost, M.D.


Robert L. Rosenthal, M.D.


Fred Gilbert, M.D.


James H. Brassel, M.D.

Menu Options

DAXOR Home Page

Mission Statement

Privacy Statement

Company Management


Contact Us




350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806

© 2014 DAXOR Corporation. All Rights Reserved.